Tag: startups

What Comes Next? OurCrowd Team Shares Top 10 Pandemic Tech Trends

For the past number of months, our global community has been focused on combating COVID-19. During this time of uncertainty, entrepreneurs have adapted to pandemic-focused innovation. To highlight the incredible efforts of those working to help society acclimate to our new environment and improve the current state of the pandemic, OurCrowd hosted its Pandemic Innovation Conference on June 22nd. The world is different now, and every new era comes with its own set of trends. In the segment “Top 10 Pandemic Tech Trends” Labs/02 Partner Stav Erez and OurCrowd Medical Advisory Board Member Dr. Jonathan Wiesen discussed the top 10 tech trends affecting society in light of the pandemic. Say Goodbye To Your Office: The Virtual Becomes Real The future of work and remote technologies is one of the first things that comes to mind following the COVID-19 pandemic. With the distancing protocols, people have turned to remote communication platforms, but that’s just part of the virtual revolution. We’ve also seen an uptick in use of products providing digital solutions, such as TechSee, a startup that helps engineers manage...

Read More

Taking a Bite Out of Unemployment, OurCrowd Portfolio Companies Need 350 Employees

Even as the coronavirus pandemic rages, startups are offering hundreds of new jobs. The number of vacant positions at OurCrowd’s portfolio companies has risen to 350, with 90 new job vacancies added since the start of April, 41 of them in Israel. Despite Israel’s unprecedented unemployment situation, high-tech companies are still recruiting. Now that Israel has gone back to work on the downside of the virus curve, entrepreneurs and startups have a huge role to play in getting our nation back to work. OurTalent, OurCrowd’s jobs portal, currently lists 350 vacant positions from within its portfolio companies, with fresh opportunities added each week. The top recruiting companies include SixGill, BioCatch, and Locusview. OurCrowd portfolio companies offer work in Israel and around the world. There are vacancies listed in Jerusalem, Tel Aviv and other Israeli locations, but also positions across the globe including New York, Toronto, California, Brazil and Barcelona. Positions advertised on OurTalent are continuously updated as a service to our companies. Applicants are invited to contact the companies directly. While global tech giants like Uber, Lyft and Airbnb are...

Read More

In the News: Expect a ‘renaissance’ in medical innovation

Trends that began way before the virus hit − whether e-commerce, working from home, distance learning or robotic process automation − have now accelerated to light-speed. The impact of this crisis on the investment world, especially venture capital, is really interesting…A couple of things are becoming apparent: an absolute and renewed focus on healthcare and medical everything, obviously with anything related to the current crisis getting huge attention and support. This sector has been under-invested in until now, particularly in Israel. Read up on my prediction for a ‘renaissance’ in medical innovation. Last week’s webinar on Cybersecurity & Insecurity: The New World of COVID-19 shared expert views from leading cybersecurity companies. Watch the recording and register for Part II: IoT Cybersecurity and Financial Crime – The New World of COVID-19, this Thursday, May 21st at 9:00AM Los Angeles, 12:00PM New York, 7:00PM Tel Aviv.  Top Tech News data.world CEO Brett Hurt credits his team’s agility at navigating the new realities in this pandemic world as key to the company’s ability to exceed expectations. Read how Brett Hurt is leading data.world...

Read More

In the News: Coronavirus, industry reinvention & venture capital

The coronavirus crisis has created heightened awareness of healthcare challenges, which will cause more money to flow to what we have seen as traditionally underfunded areas – medtech, digital health, and research. Historically, venture investing right after major market downturns – such as after the Internet bubble burst in 2000-2002, and after the financial crisis of 2007-2009 — has proved lucrative because you’re buying at a discount. That’s a very good entry point for new venture investors. However this time, there is also a fundamental re-set and expansion of social and economic trends causing major disruption that will lead to further opportunities for those companies leading the change. Read my and others’ thoughts on “Recession, Reinvention and Opportunity” in this Israel21c piece. As organizations increasingly move their business processes online, threats to data and privacy have exploded. Join us for a webinar Thursday, May 14 at 9:00AM PDT, 12:00PM EDT, 7:00PM IDT on Cybersecurity & Insecurity: The New World of COVID-19 where experts from some of the leading cybersecurity companies around the world will explore the challenges for organizations protecting...

Read More

In the News: News from startups hard at work fighting COVID-19

We’re optimistic that the coronavirus vaccine being developed by MigVax can bring very, very good news to the world, as I told CBN. The company believes it can build off of the coronavirus vaccine they previously developed for poultry and adapt it for the human coronavirus. Hear more from me on the topic, on Israel’s Channel 13. Professor Ferid Murad of Stanford University won the 1998 Nobel Prize for discovering the role of nitric oxide in the cardiovascular system. He says the nitric oxide treatment for coronavirus by SaNOtize that proved 99% effective in killing coronavirus in lab tests at Utah State University and was approved for clinical trials by Health Canada “could be effective in treating infections, including COVID-19”. Read my thoughts here. Top Tech News Coronavirus and sports: OurCrowd portfolio company PlaySight is instrumental in bringing back tennis.  I told NoCamels, the crisis has accelerated digital tech trends at warp speed – Israeli VCs are cautiously optimistic about the future, despite pandemic.  “We’re getting closer than ever to COVID-19 vaccine clinical trials, and it is all thanks to...

Read More